Teledyne FLIR IIS announces a new stereo vision product for high accuracy robotics applications

IIBA Empowers Future Business Analysis Professionals with New Student Membership

DALI Alliance Launch Test and Certification Specifications for DALI+

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

Lantronix Announces New FOX4 and Bolero 43 Edge Compute Trackers, Expanding Its Award-Winning Telematic Gateways Family

American Energy Storage Innovations Unveils the TeraStor Configurator

Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline

EBC Financial Group Partners with United to Beat Malaria, a Campaign of the United Nations Foundation, to Protect Vulnerable Children and Their Families from Malaria

Stevie® Awards Announce Winners in 18th Annual Stevie® Awards for Sales & Customer Service

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

Notified -

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

Copenhagen Infrastructure Partners completes acquisition of New York onshore wind development portfolio